A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

Published Date: 15 May 2024

Scientists at Johns Hopkins Medicine have discovered that up to 4.5 percent of papillary nevi may be explained by particular variations in three genes linked to maintaining the length of telomeres, the protective DNA endcaps on chromosomes.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A study outlines the need for policies that enhance cancer patients' autonomy and information.

2.

Novel biomarker has potential for predicting and treating skin cancer metastasis

3.

PSMA PET: Prostate Cancer Staging Revolution Awaits RCT Data

4.

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

5.

For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot